Chorioamnionitis and Neonates; Which Strategy?

Area of Science:

• Neonatal care
• Infectious disease epidemiology
• Clinical guideline evaluation

Background:

• Chorioamnionitis (CAM) is a significant risk factor for neonatal early-onset sepsis (EOS).
• International guidelines exist for managing neonates born to mothers with CAM.
• This study evaluates local neonate care against existing guidelines.

Purpose of the Study:

• To assess the adherence and impact of international guidelines on neonates born to mothers with CAM.
• To compare clinical outcomes and interventions in neonates managed under existing guidelines.

Main Methods:

• Prospective cohort study over five years (March 2012-March 2017).
• Inclusion criteria: neonates of any gestational age born to mothers with CAM.
• Data collected on clinical findings and interventions.

Main Results:

• 1.7% of 28,988 neonates were born to mothers with CAM.
• 30.8% were preterm (≤34 weeks), 39% had low birth weight (<2500g), 58.6% were asymptomatic.
• Asymptomatic neonates had fewer abnormal tests (23.07%) but longer hospital stays when symptomatic (15.15 days vs. 2.59 days).
• Three neonates (2.75%) developed culture-positive EOS; 68.05% received antibiotics.

Conclusions:

• Current guidelines may lead to increased length of stay, laboratory tests, and antibiotic use, particularly in asymptomatic neonates.
• These practices can contribute to mother-neonate separation, nosocomial infections, antibiotic resistance, and increased healthcare costs.
• Development of new, refined guidelines is recommended to optimize neonatal care for CAM exposure.